SecBot SecBot
PRESS-RELEASE ·Filed Nov 5, 2026

PRE

Prenetics Global Limited
BULLISH
Impact 6/10
Horizonmonths Processed12d 7h ago WireGlobeNewswire
Press release · Contract
Actionable Insight ▲ Bullish

Monitor the 1H 2027 launch of Care Bears by IM8 gummy multivitamins and subsequent retail distribution announcements. The partnership's success depends on execution of the staged rollout and whether the brand can achieve meaningful shelf placement in major retail channels. Prenetics' 2027 guidance update will clarify the incremental contribution.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$16.12
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.72%
T+5 · $16.72
Vs SPY
+0.43%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $16.12entry
  2. T+1 · 11d ago −1.12%α −1.43% · $15.94
  3. T+5 · 5d ago +3.72%α +0.43% · $16.72
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Prenetics' IM8 subsidiary signed a 10-year exclusive worldwide partnership with Authentic Brands Group to launch Care Bears by IM8, a family health and wellness brand starting with gummy multivitamins in 1H 2027. Prenetics will record all revenue and pay a royalty; Authentic becomes a strategic shareholder. The deal provides a new revenue stream not included in current guidance, leveraging Care Bears' high brand awareness and IM8's rapid growth trajectory.

Key Financial Metrics

Revenue
$45.0M
+359.0% YoY
Guidance
$220M-$230M
raised

Key Facts

  • 10-year exclusive worldwide partnership with Authentic Brands Group to build Care Bears by IM8
  • Prenetics records all revenue from Care Bears by IM8 and pays a royalty to Authentic
  • Authentic becomes a strategic shareholder in Prenetics
  • Global launch of gummy multivitamins for kids and adults targeted in 1H 2027
  • Prenetics raised FY2026 revenue guidance to $220M-$230M; initiated 2027 IM8 revenue guidance of $400M+ (excludes Care Bears by IM8)
  • IM8 generated $45M revenue in Q2 2026, up ~359% YoY; reached $251M annualized revenue run-rate by July 2026
  • Global gummy supplements market projected to reach ~$47.8B by 2030 (14.4% CAGR)
  • Care Bears has ~85% global brand awareness and over $12B in lifetime retail sales

Financial Impact

Incremental revenue stream not included in 2027 guidance of $400M+; Prenetics raised FY2026 guidance to $220M-$230M; IM8 Q2 2026 revenue $45M (+359% YoY); July 2026 monthly revenue $20.9M ($251M annualized run-rate)

revenueguidance

Risk Factors

  • Execution risk: launching a new brand in a competitive gummy supplements market
  • Dependence on IM8's ability to scale production and distribution for retail (not just DTC)
  • Royalty payments to Authentic may compress margins
  • Guidance excludes Care Bears by IM8, so any delays or underperformance would not affect current projections but could disappoint long-term expectations

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3396443

Track record

25 reports on PRE

Performance horizon

8 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +46.08% at T+5 after the Aug 20, 2026 report. 11 of 12 went positive at some point.

Filters
  1. Nov 17, 2026today 6-K Bullish 5/10 Entry $15.50 Now $16.33 +5.35% settles Nov 24
  2. Nov 16, 20261d ago Press Release Bullish 5/10 Entry $16.51 Now $16.33 −1.09% settles Nov 23
  3. Nov 5, 202612d ago 6-K Bullish 6/10 Entry $16.12 to $16.72 Now $16.33 +1.30% ▲ +3.72% +0.43% vs SPY
  4. Nov 5, 202612d ago Press Release Bullish 6/10 Viewing Entry $16.12 to $16.72 Now $16.33 +1.30% ▲ +3.72% +0.43% vs SPY
  5. Nov 3, 202614d ago 6-K Neutral 3/10 Entry $16.19 to $17.23 Now $16.33 +0.86% ▲ +6.42% +7.01% vs SPY
  6. Nov 2, 202615d ago 6-K Neutral 3/10 Entry $16.47 to $17.55 Now $16.33 −0.85% ▲ +6.56% +6.48% vs SPY
  7. Oct 13, 20265w ago 6-K Bullish 5/10 Entry $21.27 to $18.63 Now $16.33 −23.23% ▼ −12.41% −11.26% vs SPY
  8. Sep 22, 20268w ago F-1/A Neutral 3/10 Entry $22.90 to $22.84 Now $16.33 −28.69% ▼ −0.26% +0.93% vs SPY
  9. Aug 26, 202611w ago 6-K Bullish 7/10 Entry $25.78 to $26.05 Now $16.33 −36.66% ▲ +1.05% +1.17% vs SPY
  10. Aug 26, 202611w ago Insider Cluster Bullish 5/10 Entry $25.78 to $26.05 Now $16.33 −36.66% ▲ +1.05% +1.17% vs SPY
Showing 10 of 25

US Market Status

Market Open · Closes in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026